Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep;6(9):e1854.
doi: 10.1002/cnr2.1854. Epub 2023 Jul 12.

The impact of the COVID-19 pandemic on the diagnosis and treatment of skin cancers, a mini review

Affiliations
Review

The impact of the COVID-19 pandemic on the diagnosis and treatment of skin cancers, a mini review

Zeinab Aryanian et al. Cancer Rep (Hoboken). 2023 Sep.

Abstract

Background: The SARS-Cov-2 pandemic has caused dermatologists around the world to adapt their practice in the aim of protecting patients with special clinical conditions such as those having skin cancers or premalignant conditions and some diagnostic or therapeutic programs would be suspended due to being infected to SARS-CoV-2. We focused the existing data in this regard through searching on PubMed, Google Scholar, and Scopus and tried to summarize recommendations for treating this group of patients in COVID era to provide a practical guide for clinicians.

Recent findings: The number of diagnosed skin cancers dropped significantly since the beginning of the pandemic, specially in the peaks of various variants of the SARS-CoV-2 infection. The new guidelines allowed even a 3-month delay in excision and recommended surgery for non-melanoma growing skin cancers.

Conclusion: Dermatologists should perform a careful, individualized risk-benefit assessment for their patients and consider some changes in routine protocols such as having a delayed diagnostic or therapeutic intervention.

Keywords: BCC; COVID-19; SCC; melanoma; premalignant lesions; skin cancer.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that there is no conflict of interest.

Similar articles

Cited by

References

    1. Best AF, Bowman M, Li J, et al. COVID‐19 severity by vaccination status in the NCI COVID‐19 and Cancer Patients Study (NCCAPS). J Natl Cancer Inst. 2023;115(5):597‐600. doi:10.1093/jnci/djad015 - DOI - PMC - PubMed
    1. Lallas A, Kyrgidis A, Manoli S‐M, et al. Delayed skin cancer diagnosis in 2020 because of the COVID‐19–related restrictions: data from an institutional registry. J Am Acad Dermatol. 2021;85(3):721‐723. - PMC - PubMed
    1. Ferrara G, De Vincentiis L, Ambrosini‐Spaltro A, et al. Cancer diagnostic delay in northern and Central Italy during the 2020 lockdown due to the coronavirus disease 2019 pandemic: assessment of the magnitude of the problem and proposals for corrective actions. Am J Clin Pathol. 2021;155(1):64‐68. - PMC - PubMed
    1. Cocuz I‐G, Cocuz M‐E, Niculescu R, et al. The impact of and adaptations due to the COVID‐19 pandemic on the histopathological diagnosis of skin pathologies, including non‐melanocyte and melanoma skin cancers—a single‐center study in Romania. Medicina. 2021;57(6):533. - PMC - PubMed
    1. Schauer A, Kulakov E, Martyn‐Simmons C, Bunker C, Edmonds E. Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in Central London. Clin Exp Dermatol. 2020;45:900. - PMC - PubMed